Galaxy Diagnostics Launches the Most Sensitive Test Available for Direct Detection of Cat Scratch Disease
Science Leader in Testing for Flea and Tick-Borne Illness Introduces Bartonella Digital ePCR™
News provided by
Share this article
Share this article
DURHAM, N.C., Feb. 2, 2021 /PRNewswire/ Galaxy Diagnostics, Inc., the science leader in sample enrichment powered testing solutions for elusive flea and tick-borne pathogens, today announced the launch of
Bartonella Digital ePCR™. This blood-based DNA test panel provides the most sensitive
direct detection of
Bartonella species infections, including cat scratch disease, trench fever, involvement in culture negative endocarditis, rheumatologic disease, neurologic disease, vasoproliferative tumors, and other Bartonella-associated diseases.